Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants

Olufade, T; Lamerato, L; Sanchez, JJG; Jiang, LK; Huang, J; Nolan, S; Rangaswami, J

Olufade, T (corresponding author), AstraZeneca, Wilmington, DE 19803 USA.

ADVANCES IN THERAPY, 2021; 38 (2): 1352

Abstract

Introduction: The DAPA-CKD trial assessed dapagliflozin in patients with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). To aid in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索